» Articles » PMID: 10861753

Expression of Proinflammatory Genes During Estrogen-induced Inflammation of the Rat Prostate

Overview
Journal Prostate
Date 2000 Jun 22
PMID 10861753
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Exposure of male Wistar rats to estradiol-17beta (E(2)) in the presence or absence of dihydrotestosterone propionate (DHT) was previously shown to result in prostate inflammation. The present study examines, for the first time, changes in the expression level of several proinflammatory genes during the course of this experimentally induced prostatitis.

Methods: Adult male Wistar rats were given chronic exposure to E(2) + DHT by capsule implantation or were injected with E(2) for short-term exposure. Semiquantitative RT-PCR was employed to measure changes in proinflammatory transcript levels in the separated lobes of the prostate after various times of exposure to estrogen with or without DHT.

Results: We observed an upregulation of IL-1beta, IL-6, MIP-2, and inducible nitric oxide synthase (iNOS) after only 4 days treatment with E(2). After 4 weeks of treatment with E(2) + DHT, a significant increase in transcript levels of IL-4, IL-5, IL-6, MIP-2, eotaxin, and iNOS was detected, while IL-1beta and TNF-alpha transcript levels only increased slightly. No increase in transcript levels for cyclooxygenase-2 (cox-2), IFN-gamma, IL-2, or IL-12 was observed.

Conclusions: Upregulation of proinflammatory transcripts occurred shortly after exposure to E(2) and well before any inflammatory cells were observed in the prostate. The pattern of gene expression resembled a T(H)2-type helper-cell response.

Citing Articles

Sex steroid hormone residues in milk and their potential risks for breast and prostate cancer.

Gao P, Li C, Gong Q, Liu L, Qin R, Liu J Front Nutr. 2024; 11:1390379.

PMID: 39285863 PMC: 11403374. DOI: 10.3389/fnut.2024.1390379.


Preclinical models and evaluation criteria of prostatitis.

He H, Luo H, Xu H, Qian B, Zou X, Zhang G Front Immunol. 2023; 14:1183895.

PMID: 37228599 PMC: 10203503. DOI: 10.3389/fimmu.2023.1183895.


Diagnostic and Management Strategies for Patients with Chronic Prostatitis and Chronic Pelvic Pain Syndrome.

Pena V, Engel N, Gabrielson A, Rabinowitz M, Herati A Drugs Aging. 2021; 38(10):845-886.

PMID: 34586623 DOI: 10.1007/s40266-021-00890-2.


Can Botulinum Toxin A Still Have a Role in Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Through Inhibition of Chronic Prostatic Inflammation?.

Chiang B, Kuo H, Liao C Toxins (Basel). 2019; 11(9).

PMID: 31546892 PMC: 6784075. DOI: 10.3390/toxins11090547.


The application of IL-10 and TNF-α in expressed prostatic secretions and prostatic exosomal protein in urine in the diagnosis of patients with chronic prostatitis.

Yin L, Tang Y, Pan A, Yang L, Zhu X, Liu Y Medicine (Baltimore). 2019; 98(33):e16848.

PMID: 31415412 PMC: 6831336. DOI: 10.1097/MD.0000000000016848.